SWI Initiates Coverage on SCYX and OCLS

SWI Initiates Coverage on Two New Stocks
SCYNEXIS, Inc and  Oculus Innovative Sciences, Inc.

Los Angeles, June 30, 2015 -- StockWatchIndex (SWI) today initiated coverage on two new stocks SCYNEXIS, Inc.(SCYX:NasdaqGM) and Oculus Innovative Sciences, Inc. (OCLS:NasdaqCM) for its QuickPicks section on

While the market gave us all a good scare yesterday by tumbling 2.1%, we at SWI think this is one of those good opportunities to by in cheap and look towards the future. Most likely this week will still be tumultuous, until the Greece, Puerto Rico and Chinese problems are behind us, but there is not reason for panic. The U.S. economy is solid and the employment numbers for this Thursday are expected to be positive. We may may be growing slow, but we are growing.

...and let's face it, Greece is not going to be a problem for the U.S., not even for the Euro Zone. Greece's economy is 2% of the European market and is smaller than that of Oregon. Just a good excuse for some on Wall Street to take profits off the table; and for others (or the same people) to buy back in cheap.

SCYNEXIS, Inc is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Its lead product candidate, SCY-078 is an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. For more information, visit See a live webcast of the company's Chief Medical Officer's recent presentation at the 10th Annual JMP Securities Life Sciences Conference at The St. Regis New York in New York City on Wednesday, June 24, 2015. The stock is trading at $9.00 on 6.29.2015.

Oculus Innovative Sciences, Inc is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company's products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at The stock is trading at $1.43 on 6.29.2015.

StockWatchIndex, LLC (SWI) is a leading edge PR, Information Marketing and Research firm with a highly frequented web site, its "Rise Above The Noise" newsletter and SWI Research site These services provide readers with information and research on new and promising public companies. The QuickPicks section on the SWI site represents the consolidated opinions of carefully selected financial analyst reports and opinions from credible Wall Street firms that we respect and frequently sample. The weekly SWI QuickPicks  Ratings Report keeps you informed about newly SWI initiated stocks and potential upgrades and downgrades in the QuickPicks section. We are not being compensated by these companies and do not necessarily hold positions in any of these stocks.  You can conveniently follow the live links for each of these stocks on for more detail.  SWI's periodical "Portfolio Performance Report" frequently reports about the performance of the stocks that we have purchased and may be trading in the SWI portfolio. Please do not miss the wealth of frequently updated news, research reports and other valuable information elsewhere on SWI, especially for the stocks on our WatchIndex page. Watch a full range of CEO and analyst interviews on our Strategic Partner site 
Google +
Good luck and please pass this newsletter on to a friend
to continue building our community.

StockWatchIndex (SWI) is not a registered investment adviser and makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise) of the information provided in the publications for its Stock Watch List or on its web sites. The provided information is not to be construed as personal financial advice, or a solicitation to buy or sell stock. Some information has been generated by what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrants any results from use of the information. We have contracted with some of the companies we present on the SWI WatchIndex or in the SWI Newsletter as public relations consultants to keep the market and especially our subscribers informed about the companies and may have been compensated in cash and/or stock and stock options. Principles of SWI may also hold positions in the stocks covered in these sections, which may be considered a potential conflict of interest. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in its Stock Watch List or in any of its other publications. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. StockWatchIndex expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. The included information is subject to change without notice.

Copyright © 2015 StockWatchIndex, LLC, All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp